|
|
ORAL CHOLERA VACCINE:
|
|
|
First licensed vaccine developed
with Gates Foundation support |
|
|
|
Efforts to accelerate the global use of new generation cholera vaccines gained significant momentum with the licensure of a new oral cholera vaccine, Shanchol™ (pictured) in India in 2009.
|
|
IVI scientists developed this vaccine, with funding from the Bill & Melinda Gates Foundation, the Government of Korea, and the Swedish International Development Cooperation Agency (SIDA), by significantly modifying a vaccine used and produced only in Vietnam so that it meets international Good Manufacturing Practice (GMP) standards and WHO production guidelines.
|
|
| |
| |
 |
| [Symposium] International Symposium on Hepatitis E - Seoul, Korea - September 15-16, 2010 |
| [Vaccinology Course] The 10th International Advanced Course on Vaccinology - Seoul, Korea - May 10-15, 2010 |
| [Symposium]2009 JST-KICOS Cooperative Programme of IFReC and IVI: Regulation of Innate Immunity - IVI, Seoul, Korea, September 18-19, 2009 |
| The First Symposium on Human Papillomavirus Vaccination in the Asia-Pacific and Middle East Regions - Seoul, Korea, June 1-2, 2009 |
| Policymakers Meeting on the Introduction of Cholera Vaccinations using New-Generation Oral Vaccines in India - New Delhi, India - 2009-04-10 |
|
| |
|
